We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Renal Cell Carcinoma

Journal Scan / Research · October 06, 2020

Patients With mRCC of T4 Stage With N1 Stage or Who Are Older Than 76 Years Do Not Benefit From Cytoreductive Nephrectomy

BMC Cancer

 

Additional Info

BMC Cancer
Metastatic Renal Cell Carcinoma Patients of T4 Stage Who Are in Status of N1 Stage or Older Than 76 Years Cannot Benefit From Cytoreductive Nephrectomy
BMC Cancer 2020 Sep 03;20(xx)844, Z Zhang, H Wu, T Yang, Y Wu, N Yu, Z Xu

Further Reading